CD8A and COVID-19: We applied MeDuSA to RNA-seq data from patients with coronavirus disease 2019 (COVID-19), with the aim to portray the dynamics of CD8+ T cells during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.